Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- Importance of Personal Relationships, Low Use of Generics Contribute to Persistence of SOV Model in Japan, but Change is Likely
July 5, 2013
- MTPC Begins Construction of New Head Office Building, Expects Completion in January 2015
July 4, 2013
- Generic Industry Needs to Produce 30 Billion More Tablets to Meet 60% Generic Share Goal: Sawai President
July 4, 2013
- Out-Licensed OAB Treatment Imidafenacin Launched in South Korea: Kyorin Holdings
July 4, 2013
- Low-Dose Lunabell Approved
July 4, 2013
- Manipulation of BMI Data in Kobayashi Pharmaceutical’s Anti-Obesity Drug Clinical Study Suspected
July 3, 2013
- Sandoz to Ratchet Up Promotions for General Practitioners, Dispensing Pharmacies
July 3, 2013
- Latuda Approved for Major Depressive Episodes Associated with Bipolar I Disorder in the US: DSP
July 3, 2013
- Japanese Society of Chemotherapy Joins Hands with Pharmas, Govt to Spur New Antibiotic Development
July 2, 2013
- DSP Adopts Tokyo-Osaka Two Head Office System
July 2, 2013
- Takeda Withdraws European MAA for Anemia Treatment Peginesatide Following Voluntary Recall in US
July 2, 2013
- Gout, Hyperuricemia Treatment Topiloric/Uriadec Tablets Approved: Fuji Yakuhin, Sanwa Kagaku
July 2, 2013
- Astellas’ US Affiliate Agensys to Codevelop ADC with Seattle Genetics
July 1, 2013
- Kyowa Kirin Files NDA for Sustained-Duration G-CSF KRN125, PEGylated Form of Gran
July 1, 2013
- Takeda President Executive Pay Reaches 300 Million Yen, Three Execs Receive Over 700 Million Yen
June 28, 2013
- Novartis Files Combination Drug for Parkinson’s Disease in Japan
June 28, 2013
- Bayer Yakuhin to Shift Resources to Innovative New Drugs: President Brunn
June 28, 2013
- Reasons for Doctors’ Reluctance to Generic Name Prescribing is Time and Effort: CareNet Survey
June 28, 2013
- Tsumura Reports Record Profits through Intensified MR Activities to Educate Doctors about Kampo Medicine
June 28, 2013
- Astellas Begins Global PIII Study of Cytomegalovirus Vaccine
June 27, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…